Published in Br J Dermatol on March 01, 2005
Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system. Adv Anat Embryol Cell Biol (2012) 2.99
Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets. CNS Neurol Disord Drug Targets (2006) 1.97
Key role of CRF in the skin stress response system. Endocr Rev (2013) 1.77
Corticotropin releasing hormone and the skin. Front Biosci (2006) 1.45
CRH functions as a growth factor/cytokine in the skin. J Cell Physiol (2006) 1.38
Substance P (SP) induces expression of functional corticotropin-releasing hormone receptor-1 (CRHR-1) in human mast cells. J Invest Dermatol (2011) 1.03
Emerging role of alternative splicing of CRF1 receptor in CRF signaling. Acta Biochim Pol (2010) 0.97
Brain-skin connection: stress, inflammation and skin aging. Inflamm Allergy Drug Targets (2014) 0.95
Modulation of the human hair follicle pigmentary unit by corticotropin-releasing hormone and urocortin peptides. FASEB J (2006) 0.90
Detection of intracellular granularity induction in prostate cancer cell lines by small molecules using the HyperCyt high-throughput flow cytometry system. J Biomol Screen (2009) 0.87
Neuroendocrinology of the skin: An overview and selective analysis. Dermatoendocrinol (2011) 0.81
Cutaneous induction of corticotropin releasing hormone by Propionibacterium acnes extracts. Dermatoendocrinol (2009) 0.76
CP-154,526 Modifies CREB Phosphorylation and Thioredoxin-1 Expression in the Dentate Gyrus following Morphine-Induced Conditioned Place Preference. PLoS One (2015) 0.75
Synthesis and Evaluation of Biological Activity of Antimicrobial - Pro-Proliferative Peptide Conjugates. PLoS One (2015) 0.75
Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol (1988) 16.82
The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA (1992) 6.96
Neuroendocrinology of the skin. Endocr Rev (2000) 3.34
Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev (2000) 2.98
Ionic calcium reservoirs in mammalian epidermis: ultrastructural localization by ion-capture cytochemistry. J Invest Dermatol (1985) 2.12
Corticotropin releasing factor receptors and their ligand family. Ann N Y Acad Sci (1999) 2.04
Function and regulation of AP-1 subunits in skin physiology and pathology. Oncogene (2001) 1.91
IFNalpha/beta promotes cell survival by activating NF-kappa B. Proc Natl Acad Sci U S A (2000) 1.74
Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. FASEB J (2001) 1.74
Alternative splicing of CRH-R1 receptors in human and mouse skin: identification of new variants and their differential expression. FASEB J (2001) 1.59
Differential expression of a cutaneous corticotropin-releasing hormone system. Endocrinology (2003) 1.46
Corticotrophin-releasing factor receptors: from molecular biology to drug design. Trends Pharmacol Sci (1996) 1.40
Calcium- and vitamin D-regulated keratinocyte differentiation. Mol Cell Endocrinol (2001) 1.38
Cutaneous expression of CRH and CRH-R. Is there a "skin stress response system?". Ann N Y Acad Sci (1999) 1.18
Pleiotropic effects of corticotropin releasing hormone on normal human skin keratinocytes. In Vitro Cell Dev Biol Anim (2001) 1.07
Corticotropin releasing hormone and related peptides can act as bioregulatory factors in human keratinocytes. In Vitro Cell Dev Biol Anim (2000) 1.04
Proopiomelanocortin, corticotropin releasing hormone and corticotropin releasing hormone receptor genes are expressed in human skin. FEBS Lett (1995) 1.02
Corticotropin-releasing hormone affects cytokine production in human HaCaT keratinocytes. Life Sci (2002) 0.99
Monitoring human neutrophil granule secretion by flow cytometry: secretion and membrane potential changes assessed by light scatter and a fluorescent probe of membrane potential. J Leukoc Biol (1985) 0.99
In situ expression of corticotropin-releasing hormone (CRH) and proopiomelanocortin (POMC) genes in human skin. FASEB J (2001) 0.98
Inhibition of mouse melanoma cell proliferation by corticotropin-releasing hormone and its analogs. Anticancer Res (2001) 0.98
Effect of CRF and related peptides on calcium signaling in human and rodent melanoma cells. FEBS Lett (1998) 0.97
Intracellular calcium measurements of single human skin cells after stimulation with corticotropin-releasing factor and urocortin using confocal laser scanning microscopy. J Cell Sci (2003) 0.94
Corticotropin-releasing hormone inhibits nuclear factor-kappaB pathway in human HaCaT keratinocytes. J Invest Dermatol (2003) 0.92
D-amino acid-substituted analogs of corticotropin-releasing hormone (CRH) and urocortin with selective agonist activity at CRH1 and CRH2beta receptors. Peptides (1998) 0.89
Neuroendocrinology of the skin. Endocr Rev (2000) 3.34
Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev (2000) 2.98
Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab (1987) 2.35
Racial pigmentation and the cutaneous synthesis of vitamin D. Arch Dermatol (1991) 2.33
beta-endorphin is a potent analgesic agent. Proc Natl Acad Sci U S A (1976) 2.30
Age, vitamin D, and solar ultraviolet. Lancet (1989) 1.82
Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. FASEB J (2001) 1.74
The effect of standard- and high-dose epinephrine on coronary perfusion pressure during prolonged cardiopulmonary resuscitation. JAMA (1991) 1.74
Maltreatment of boys and the development of disruptive and delinquent behavior. Dev Psychopathol (2001) 1.70
Alternative splicing of CRH-R1 receptors in human and mouse skin: identification of new variants and their differential expression. FASEB J (2001) 1.59
Detection of proopiomelanocortin-derived antigens in normal and pathologic human skin. J Lab Clin Med (1993) 1.58
Glycosaminoglycans in histologic sections. Arch Dermatol (1987) 1.39
CRH functions as a growth factor/cytokine in the skin. J Cell Physiol (2006) 1.38
High basal NF-κB activity in nonpigmented melanoma cells is associated with an enhanced sensitivity to vitamin D3 derivatives. Br J Cancer (2011) 1.35
Chronic sunscreen use decreases circulating concentrations of 25-hydroxyvitamin D. A preliminary study. Arch Dermatol (1988) 1.30
Parathyroid cell surface autoantibodies that inhibit parathyroid hormone secretion from dispersed human parathyroid cells. J Bone Miner Res (1986) 1.27
Ultraviolet radiation regulates cortisol activity in a waveband-dependent manner in human skin ex vivo. Br J Dermatol (2013) 1.21
Asbestos: mechanisms of toxicity and carcinogenicity in the respiratory tract. Annu Rev Pharmacol Toxicol (1983) 1.21
Human plasma transport of vitamin D after its endogenous synthesis. J Clin Invest (1993) 1.20
Clothing prevents ultraviolet-B radiation-dependent photosynthesis of vitamin D3. J Clin Endocrinol Metab (1992) 1.20
Cutaneous expression of CRH and CRH-R. Is there a "skin stress response system?". Ann N Y Acad Sci (1999) 1.18
Metabolism of progesterone to DOC, corticosterone and 18OHDOC in cultured human melanoma cells. FEBS Lett (1999) 1.17
Active steroidogenesis in the normal rat skin. Biochim Biophys Acta (2000) 1.17
A characterization of hypothalamic-pituitary-adrenal axis function during and after human cardiac arrest. Crit Care Med (1993) 1.12
Celiac disease-associated autoimmune endocrinopathies. Clin Diagn Lab Immunol (2001) 1.10
Pleiotropic effects of corticotropin releasing hormone on normal human skin keratinocytes. In Vitro Cell Dev Biol Anim (2001) 1.07
Kinetic and thermodynamic studies of the conversion of previtamin D3 to vitamin D3 in human skin. J Biol Chem (1993) 1.07
Characterization of corticotropin-releasing hormone (CRH) in human skin. J Clin Endocrinol Metab (1998) 1.06
Thyrotrophin-releasing hormone and shaking behaviour in rat. Nature (1975) 1.06
Adrenomedullary response to maximal stress in humans. Am J Med (1984) 1.04
What's the use of generating melanin? Exp Dermatol (1999) 1.04
Family-based association test method: age of onset traits and covariates. Genet Epidemiol (2001) 1.04
On the potential role of proopiomelanocortin in skin physiology and pathology. Mol Cell Endocrinol (1993) 1.04
Corticotropin releasing hormone and related peptides can act as bioregulatory factors in human keratinocytes. In Vitro Cell Dev Biol Anim (2000) 1.04
Malignant melanoma. Arch Pathol Lab Med (2001) 1.04
Compensation for the interracial variance in the cutaneous synthesis of vitamin D. J Lab Clin Med (1995) 1.03
Oncostatic effects of the indole melatonin and expression of its cytosolic and nuclear receptors in cultured human melanoma cell lines. Int J Oncol (2006) 1.02
The skin produces urocortin. J Clin Endocrinol Metab (2000) 1.01
Melatonin increases survival of HaCaT keratinocytes by suppressing UV-induced apoptosis. J Pineal Res (2006) 1.01
Airborne mutagens bioassayed in Salmonella typhimurium. J Natl Cancer Inst (1977) 1.01
Quantitative aspects of precipitated abstinence in morphine-dependent rats. J Pharmacol Exp Ther (1973) 1.00
Modification of melanogenesis in cultured human melanoma cells. In Vitro Cell Dev Biol Anim (2000) 1.00
Central cardiovascular effects of enkephalins and C-fragment of lipotropin [proceedings]. J Physiol (1978) 0.99
Steroidogenesis in the human skin: 21-hydroxylation in cultured keratinocytes. J Steroid Biochem Mol Biol (2001) 0.99
Molecular pathology of soft tissue and bone tumors. A review. Arch Pathol Lab Med (1999) 0.98
In vivo threshold for cutaneous synthesis of vitamin D3. J Lab Clin Med (1989) 0.98
Endorphins may function in heat adaptation. Proc Natl Acad Sci U S A (1978) 0.98
Adrenal insufficiency in high-risk surgical ICU patients. Chest (2001) 0.97
Brain sites of precipitated abstinence in morphine-dependent rats. J Pharmacol Exp Ther (1973) 0.97
Liquid chromatography-mass spectrometry detection of corticotropin-releasing hormone and proopiomelanocortin-derived peptides in human skin. J Clin Endocrinol Metab (2000) 0.96
Use of topical sunscreen for the evaluation of regional synthesis of vitamin D3. J Am Acad Dermatol (1990) 0.95
Plasma catecholamine and serum cortisol responses to experimental cardiac arrest in dogs. Am J Physiol (1987) 0.94
Central sites at which morphine acts when producing cardiovascular effects [proceedings]. J Physiol (1978) 0.93
Ultrasound detection and identification of cosmetic fillers in the skin. J Eur Acad Dermatol Venereol (2011) 0.93
The measurement of intestinal calcium absorption by external radioisotope counting: application to study of nephrolithiasis. Clin Sci (1970) 0.93
Alkaline phosphatase (EC 3.1.3.1) in serum is inhibited by physiological concentrations of inorganic phosphate. J Clin Endocrinol Metab (1998) 0.93
Influence of dietary factors on the gastrointestinal absorption of lead. Toxicol Appl Pharmacol (1974) 0.92
Melatonin maintains mitochondrial membrane potential and attenuates activation of initiator (casp-9) and effector caspases (casp-3/casp-7) and PARP in UVR-exposed HaCaT keratinocytes. J Pineal Res (2007) 0.92
Effect of obesity on the clinical and hormonal characteristics of the polycystic ovary syndrome. J Reprod Med (1994) 0.92
Physical dependence of opiate-like peptides. Science (1976) 0.92
Plasma chromogranin A as a marker of sympathochromaffin activity in humans. Am J Physiol (1991) 0.89
Stress and the skin. G Ital Dermatol Venereol (2010) 0.88
Sonography in pathologies of scalp and hair. Br J Radiol (2012) 0.88
Characterization of a large molecular weight prolactin in women with idiopathic hyperprolactinemia and normal menses. J Clin Endocrinol Metab (1985) 0.88
Neuroanatomical correlates of morphine dependence. Science (1972) 0.88
Sex steroid levels during treatment of endometriosis. Obstet Gynecol (1979) 0.88
Spinal meningeal AVM supplied from the internal iliac artery associated with tethered cord syndrome in an adult: case report. J Can Assoc Radiol (1983) 0.87
Melanotropic activity of gamma MSH peptides in melanoma cells. Life Sci (1992) 0.87
Ocular toxicity of paraquat. Bull Environ Contam Toxicol (1973) 0.87
Spectrum of endocrine abnormalities associated with acanthosis nigricans. Am J Med (1987) 0.86
Regional sensitivity of the rat brain to the inhibitory effects of morphine on wet shake behavior. J Pharmacol Exp Ther (1975) 0.86
Assessment of precipitated abstinence in morphine- dependent rats. Psychopharmacologia (1973) 0.84
Thyroid hormones homeostasis in rats refed after short-term and prolonged fasting. J Endocrinol Invest (1996) 0.83
Stress-mediated decrease in liver hexobarbital metabolism: the role of corticosterone and somatotropin. J Pharmacol Exp Ther (1971) 0.83
Microassay of phosphate provides a general method for measuring the activity of phosphatases using physiological, nonchromogenic substrates such as lysophosphatidic acid. Anal Biochem (2001) 0.83
Celiac disease and hypoparathyroidism: cross-reaction of endomysial antibodies with parathyroid tissue. Clin Diagn Lab Immunol (1996) 0.83
Vasopressin can increase coronary perfusion pressure during human cardiopulmonary resuscitation. Acad Emerg Med (1997) 0.82
The role of parathyroid hormone in the gastro-intestinal absorption of calcium. Clin Sci (1970) 0.82
Morphine analgesia, tolerance and physical dependence in the adrenalectomized rat. Br J Pharmacol (1973) 0.82
Can some melanotropins modulate keratinocyte proliferation? J Invest Dermatol (1991) 0.82
The significance of the "active" E-rosette-forming cell. Clin Immunol Immunopathol (1979) 0.82
Angiotensinogen gene polymorphisms M235T/T174M: no excess transmission to hypertensive Chinese. Hypertension (1999) 0.82
Decreased nuclear uptake of [125I]triiodo-L-thyronine in fibroblasts from patients with peripheral thyroid hormone resistance. J Clin Endocrinol Metab (1984) 0.81
Elevated levels of plasma beta-endorphin and gamma 3-melanocyte stimulating hormone in the polycystic ovary syndrome. Obstet Gynecol (1984) 0.81
Human skin expresses growth hormone but not the prolactin gene. J Lab Clin Med (2000) 0.81
Cancer in cystic lesions of the thyroid. Arch Surg (1982) 0.81
Skin types and epidermal photosynthesis of vitamin D3. J Am Acad Dermatol (1990) 0.81
Effects of resveratrol on oxidative modification of human low density lipoprotein. Chin Med J (Engl) (2000) 0.81
Modulation of corticotropin releasing factor (CRF) signaling through receptor splicing in mouse pituitary cell line AtT-20--emerging role of soluble isoforms. J Physiol Pharmacol (2009) 0.81
Heparin and nitric oxide treatment in experimental acute pancreatitis in rats. Forum (Genova) (1998) 0.81
Acanthosis nigricans in a patient with streak gonads. Arch Intern Med (1983) 0.80
Indomethacin inhibits kidney metastasis in bomirski melanoma-bearing hamsters, and modulates natural killer cytotoxic activity of tumor hosts in vivo and in vitro. Anticancer Res (1998) 0.80
Ultrastructural characteristics of keloid fibroblasts. Am J Dermatopathol (1988) 0.80
Similarity of morphine abstinence signs to thermoregulatory behaviour. Nature (1974) 0.80
Familial resistance to thyroid hormone associated with decreased transport across the plasma membrane. Ann Intern Med (1983) 0.80